These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 59842)

  • 41. [Hodgkin's disease in the practice of general medicine. Problems posed by the diagnosis, surveillance of treatments and social rehabilitation of patients].
    Huart M
    Rev Prat; 1974 Oct; 24(45):3995-8. PubMed ID: 4216953
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical and therapeutic aspects of non-Hodgkin lymphoma with primary digestive localization].
    Stoica I; Gociu M; Moţoiu I; Coliţă D; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):11-8. PubMed ID: 6203154
    [No Abstract]   [Full Text] [Related]  

  • 43. [The practice of chemotherapy with the DeVita protocol].
    Gassmann W; Schmitz N; Löffler H
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1063-9. PubMed ID: 6177488
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy of non-Hodgkin lymphomas].
    Izzi T; Porcellini A; Delfini C; Lucarelli G
    Minerva Med; 1982 Apr; 73(15):949-53. PubMed ID: 7078792
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug therapy of malignant lymphoma].
    Ogawa M; Inagaki J
    Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
    [No Abstract]   [Full Text] [Related]  

  • 46. [Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy].
    Marinone G; Maiolini E; Buttolo Q; Mauro PL; Colle R
    Minerva Med; 1975 Apr; 66(31):1466-71. PubMed ID: 48218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppressive and cytotoxic drugs in dermatology.
    Dantzig PI
    Arch Dermatol; 1974 Sep; 110(3):393-406. PubMed ID: 4141602
    [No Abstract]   [Full Text] [Related]  

  • 48. Induction chemotherapy of non-Hodgkin's malignant lymphomas. Preliminary results of a controlled trial.
    Chauvergne J; Durand M; Hoerni B; Hoerni-Simon G; Brunet R; Lagarde C
    Eur J Cancer (1965); 1977; 13(4-5):399-400. PubMed ID: 326551
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chemotherapy of the ovarian carcinoma (author's transl)].
    Bruntsch U; Gallmeier WM
    Strahlentherapie; 1977 May; 153(5):325-30. PubMed ID: 406695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
    Nissen NI; Stutzman L; Holland JF; Glidewell OJ
    Arch Intern Med; 1973 Mar; 131(3):396-401. PubMed ID: 4688038
    [No Abstract]   [Full Text] [Related]  

  • 51. Non-Hodgkin's lymphomas. II. Single agent chemotherapy.
    Jones SE; Rosenberg SA; Kaplan HS; Kadin ME; Dorfman RF
    Cancer; 1972 Jul; 30(1):31-8. PubMed ID: 4557278
    [No Abstract]   [Full Text] [Related]  

  • 52. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Clamon GH; Corder MP
    Cancer Treat Rep; 1978 Mar; 62(3):363-7. PubMed ID: 77188
    [No Abstract]   [Full Text] [Related]  

  • 54. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy.
    Ortega J
    Cancer; 1977 Dec; 40(6):2829-35. PubMed ID: 73411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-Hodgkin's lymphoma: recent observations on natural history and intensive treatment.
    Carbone PP
    Cancer; 1972 Dec; 30(6):1511-6. PubMed ID: 4565816
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
    Case DC; Young CW; Lee BJ
    Cancer; 1977 Apr; 39(4):1382-6. PubMed ID: 66972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
    Krikorian JG; Portlock CS; Rosenberg SA
    Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long term experience with combination chemotherapy in advanced Hodgkin's disease.
    Garrett MJ; Das S; Smith JD; Freedman LS
    Clin Oncol; 1977 Jun; 3(2):145-54. PubMed ID: 68843
    [No Abstract]   [Full Text] [Related]  

  • 60. Hodgkin's lymphoma--the great teacher.
    Connors JM
    N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.